Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease

Aliment Pharmacol Ther. 2015 Oct;42(7):939-40. doi: 10.1111/apt.13335.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Colitis, Ulcerative / drug therapy*
  • Crohn Disease / drug therapy*
  • Humans
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Tumor Necrosis Factor-alpha